首页> Multiple sclerosis and related disorders> Barriers to accessing multiple sclerosis disease-modifying therapies in the Middle East and North Africa region: A regional survey-based study.

Barriers to accessing multiple sclerosis disease-modifying therapies in the Middle East and North Africa region: A regional survey-based study.

导出 LinkOut

翻译打印收藏纠错

第一作者： Maya,Zeineddine

第一单位： Inserm U1094, IRD U270, University Limoges, CHU Limoges, EpiMaCT - Epidemiology of Chronic Diseases in Tropical Zone, Institute of Epidemiology and Tropical Neurology, Omega Health, Limoges, France; Neurology Institute, Harley Street Medical Center, Abu Dhabi, United Arab Emirates. Electronic address: mzeineddine39@gmail.com.

作者： Maya,Zeineddine ^[1] ; Amal,Al-Hajje ^[2] ; Pascale,Salameh ^[3] ; Anne,Helme ^[4] ; Michael Gunnar,Thor ^[4] ; Farid,Boumediene ^[5] ; Bassem,Yamout ^[6]

作者单位： Inserm U1094, IRD U270, University Limoges, CHU Limoges, EpiMaCT - Epidemiology of Chronic Diseases in Tropical Zone, Institute of Epidemiology and Tropical Neurology, Omega Health, Limoges, France; Neurology Institute, Harley Street Medical Center, Abu Dhabi, United Arab Emirates. Electronic address: mzeineddine39@gmail.com. ^[1] Faculty of Pharmacy, Lebanese University, Beirut, Lebanon; National Institute of Public Health, Clinical Epidemiology and Toxicology (INSPECT-LB), Beirut, Lebanon. ^[2] Faculty of Pharmacy, Lebanese University, Beirut, Lebanon; National Institute of Public Health, Clinical Epidemiology and Toxicology (INSPECT-LB), Beirut, Lebanon; School of Medicine, Lebanese American University, Byblos, Lebanon; Department of Primary Care and Population Health, University of Nicosia Medical School, Nicosia 2417, Cyprus. ^[3] Multiple Sclerosis International Federation, London, United Kingdom. ^[4] Inserm U1094, IRD U270, University Limoges, CHU Limoges, EpiMaCT - Epidemiology of Chronic Diseases in Tropical Zone, Institute of Epidemiology and Tropical Neurology, Omega Health, Limoges, France. ^[5] Neurology Institute, Harley Street Medical Center, Abu Dhabi, United Arab Emirates. ^[6]

关键词 Access Barriers Disease-modifying therapies MENA Multiple sclerosis Treatment

医学主题词人类(Humans);多发性硬化(Multiple Sclerosis);中东(Middle East);非洲, 北部(Africa, Northern);干扰素类(Interferons)

DOI 10.1016/j.msard.2023.104959

PMID 37651815

发布时间 2023-11-10

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交